Filtered By:
Education: Learning
Management: Hospitals

This page shows you your search results in order of date. This is page number 7.

Order by Relevance | Date

Total 273 results found since Jan 2013.

Decision-Making on Referral to Primary Care Physiotherapy After Inpatient Stroke Rehabilitation
Worldwide, stroke is a leading cause of death and disability.1 Although incidence rates are expected to increase over the next few decades, survival rates are expected to improve. Consequently, more stroke survivors will have to learn to live with the consequences. After acute stroke care or rehabilitation, returning home is one of the primary goals for stroke survivors.2 In the Netherlands, 65 % of stroke survivors return home immediately after acute hospital care.3 The remaining 35% continue inpatient rehabilitation in a rehabilitation center (RC) or geriatric rehabilitation center (GRC) before returning home.
Source: Journal of Stroke and Cerebrovascular Diseases - February 23, 2021 Category: Neurology Authors: Marieke Geerars, Roderick Wondergem, Martijn F. Pisters Source Type: research

Imaging-Based Outcome Prediction of Acute Intracerebral Hemorrhage
AbstractWe hypothesized that imaging-only-based machine learning algorithms can analyze non-enhanced CT scans of patients with acute intracerebral hemorrhage (ICH). This retrospective multicenter cohort study analyzed 520 non-enhanced CT scans and clinical data of patients with acute spontaneous ICH. Clinical outcome at hospital discharge was dichotomized into good outcome and poor outcome using different modified Rankin Scale (mRS) cut-off values. Predictive performance of a random forest machine learning approach based on filter- and texture-derived high-end image features was evaluated for differentiation of functional ...
Source: Translational Stroke Research - February 6, 2021 Category: Neurology Source Type: research

Scientists jump-start two people ’s brains after coma
In 2016, a team led by UCLA ’s Martin Monti reported that a 25-year-old man recovering from a coma had made remarkable progress following a treatment to jump-start his brain using ultrasound.Wired U.K. called the news one of the  best things that happened in 2016. At the time, Monti acknowledged that although he was encouraged by the outcome, it was possible the scientists had gotten a little lucky.Now, Monti and colleagues report that two more patients with severe brain injuries — both had been in what scientists call a long-term “minimally conscious state” — have made impressive progress thanks to the same te...
Source: UCLA Newsroom: Health Sciences - January 27, 2021 Category: Universities & Medical Training Source Type: news

Will MRI replace the EEG for the diagnosis of nonconvulsive status epilepticus, especially focal?
Authors: Gelisse P, Genton P, Crespel A, Lefevre PH Abstract Magnetic resonance imaging (MRI) can now be used to diagnose or to provide confirmation of focal nonconvulsive status epilepticus (NCSE). Approximately half of patients with status epilepticus (SE) have signal changes. MRI can also aid in the differential diagnosis with generalized NCSE when there is a clinical or EEG doubt, e.g. with metabolic/toxic encephalopathies or Creutzfeldt-Jakob disease. With the development of stroke centers, MRI is available 24h/24 in most hospitals. MRI has a higher spatial resolution than electroencephalography (EEG). MRI wit...
Source: Revue Neurologique - January 26, 2021 Category: Neurology Tags: Rev Neurol (Paris) Source Type: research

Integrating New Staff into Endovascular Stroke-Treatment Workflows in the COVID-19 Pandemic INTERVENTIONAL
SUMMARY: A health care crisis such as the coronavirus disease 2019 (COVID-19) pandemic requires allocation of hospital staff and resources on short notice. Thus, new and sometimes less experienced team members might join the team to fill in the gaps. This scenario can be particularly challenging in endovascular stroke treatment, which is a highly specialized task that requires seamless cooperation of numerous health care workers across various specialties and professions. This document is intended for stroke teams who face the challenge of integrating new team members into endovascular stroke-treatment workflows during the...
Source: American Journal of Neuroradiology - January 11, 2021 Category: Radiology Authors: Goyal, M., Kromm, J., Ganesh, A., Wira, C., Southerland, A., Sheth, K. N., Khosravani, H., Panagos, P., McNair, N., Ospel, J. M., On behalf of the AHA/ASA Stroke Council Science Subcommittees: Emergency Neurovascular Care (ENCC), the Cardiovascular and St Tags: INTERVENTIONAL Source Type: research

New XARELTO ® (rivaroxaban) Peripheral Artery Disease (PAD) Data from EXPLORER Clinical Research Program to be Unveiled at American Heart Association (AHA) Scientific Sessions 2020
RARITAN, N.J., November 9, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that 10 data presentations will be shared at the virtual American Heart Association (AHA) Scientific Sessions 2020 from November 13-17. Most notably, four new sub-analyses of XARELTO® (rivaroxaban) from the landmark VOYAGER PAD trial, part of the EXPLORER global cardiovascular research program, will be presented, including two live, featured science oral presentations. “We're pleased VOYAGER PAD was selected to be front and center once again at a major medical congress, as there's an urgent need for data in ...
Source: Johnson and Johnson - November 9, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen Submits Application to U.S. FDA for New Indication to Expand Use of XARELTO ® (rivaroxaban) in Patients with Peripheral Artery Disease
RARITAN, NJ, October 26, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for a new indication to expand the use of XARELTO® (rivaroxaban) in patients with peripheral artery disease (PAD). If approved, this new indication for the XARELTO® vascular dose (2.5 mg twice daily plus aspirin 75-100 mg once daily) would include reducing the risk of major thrombotic vascular events such as heart attack, stroke and amputation in patients after recent lower-extremity revascularization, a c...
Source: Johnson and Johnson - October 26, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

' Weekend Effect ' Affects Survival Odds for Rural Stroke Patients
WEDNESDAY, Oct. 21, 2020 -- Stroke patients have a higher risk of death if they ' re admitted to a rural hospital on the weekend, a new study finds. University of Georgia researchers analyzed 2016 data on stroke deaths at U.S. hospitals to learn...
Source: Drugs.com - Daily MedNews - October 21, 2020 Category: General Medicine Source Type: news

Role of Artificial Intelligence in TeleStroke: An Overview
Teleneurology has provided access to neurological expertise and state-of-the-art stroke care where previously they have been inaccessible. The use of Artificial Intelligence with machine learning to assist telestroke care can be revolutionary. This includes more rapid and more reliable diagnosis through imaging analysis as well as prediction of hospital course and 3-month prognosis. Intelligent Electronic Medical Records can search free text and provide decision assistance by analyzing patient charts. Speech recognition has advanced enough to be reliable and highly convenient. Smart contextually aware communication and ale...
Source: Frontiers in Neurology - October 6, 2020 Category: Neurology Source Type: research

What Are the Main Acyanotic Congenital Heart Diseases?
Discussion Congenital heart diseases (CHD) are malformations of the heart and great vessels. It occurs in about 5-8/1000 live births. Cyanotic congenital heart disease is often noted perinatally because of cyanosis, respiratory distress and/or poor feeding or other distress type problems. A review can be found here. Acyanotic congenital heart disease (ACHD) can present at birth but often is seen in older children or adults unless the lesions are severe, especially obstructive lesions. Severe lesions may also cause cyanosis and distress type problems in patients also. Shunting lesions cause problems by diverting blood flo...
Source: PediatricEducation.org - August 17, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Toward automatic evaluation of medical abstracts: The current value of sentiment analysis and machine learning for classification of the importance of PubMed abstracts of randomized trials for stroke
The exponential growth of the number of medical publications makes it more and more difficult for the clinical practitioner to keep track of relevant scientific progress. Computer-aided screening and analysis might help to overview and classify the content of medical publications more efficiently. The new wave of enthusiasm for machine learning algorithms has launched several new possibilities to analyze and categorize documents, ranging from sports news to hospital discharge summaries. Search algorithms for the medical literature, i.e.
Source: Journal of Stroke and Cerebrovascular Diseases - August 15, 2020 Category: Neurology Authors: Igor Fischer, Hans-Jakob Steiger Source Type: research

Study Documents Neurological, Psychiatric Complications From COVID-19
While previous studies and case reports have found that COVID-19 patients have experienced vascular and neurological problems, a newstudy inthe Lancet Psychiatry reports that patients are also showing symptoms of psychiatric disorders, including psychosis and depression.The study was the result of a collaborative effort of specialists in the United Kingdom to document COVID-19 complications.“To our knowledge, this is the first systematic, nationwide U.K. surveillance study of the breadth of acute complications of COVID-19 in the nervous system,” wrote Aravinthan Varatharaj, M.R.C.P., of University Hospital Southampton ...
Source: Psychiatr News - June 29, 2020 Category: Psychiatry Tags: Aravinthan Varatharaj brain hemorrhage brain inflammation cognition COVID-19 depression Lancet Psychiatry pain psychiatric disorders psychosis stroke United Kingdom weakness Source Type: research

Feasibility of Wearable Sensing for In-Home Finger Rehabilitation Early After Stroke
Wearable grip sensing shows potential for hand rehabilitation, but few studies have studied feasibility early after stroke. Here, we studied a wearable grip sensor integrated with a musical computer game (MusicGlove). Among the stroke patients admitted to a hospital without limiting complications, 13% had adequate hand function for system use. Eleven subjects used MusicGlove at home over three weeks with a goal of nine hours of use. On average they achieved 4.1 ± 3.2 (SD) hours of use and completed 8627 ± 7500 grips, an amount comparable to users in the chronic phase of stroke measured in a previous st...
Source: IEE Transactions on Neural Systems and Rehabilitation Engineering - May 31, 2020 Category: Neuroscience Source Type: research

Coronavirus May Pose a New Risk to Younger Patients: Strokes
Doctors have reported a flurry of cases in Covid-19 patients — including a healthy 27-year-old emergency medical technician in Queens. After a month in the hospital, he is learning to walk again.
Source: NYT Health - May 14, 2020 Category: Consumer Health News Authors: Roni Caryn Rabin Tags: your-feed-science Deep-Vein Thrombosis Seizures (Medical) Stroke Fever Emergency Medical Treatment Coronavirus (2019-nCoV) Ventilators (Medical) Hospitals Brain Blood Clots Lungs Quarantines Mount Sinai Medical Center New Engla Source Type: news

Biosense Webster Unveils Late-Breaking Results from PRECEPT Study in Patients with Persistent Atrial Fibrillation
IRVINE, CA – May 8, 2020 – Johnson & Johnson Medical Devices Companies* today announced that Biosense Webster, Inc.’s THERMOCOOL SMARTTOUCH® SF Ablation Catheter, evaluated in the PRECEPT study for the treatment of persistent atrial fibrillation (AF), resulted in freedom from any documented, symptomatic atrial arrhythmias at 15 months post-procedure for eight out of ten study participants (80.4 percent).1 Use of the THERMOCOOL SMARTTOUCH SF CATHETER for persistent atrial fibrillation is investigational only. This PRECEPT study data support a Premarket Approval supplement application to the U.S. Food and Drug Adm...
Source: Johnson and Johnson - May 12, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news